MMATISS has developed specialized systems for prompt initiation and effective operation. These include computerized patient screening. Other specialty service include providing project specific Regulatory Affairs and information to physicians, patients and patient advocacy groups.
MMATISS achieves satisfactory and consistent results in clinical studies, as well as a low patient drop-out due to:
Latin America has enormous possibilities to recruit patients quickly and efficiently, considering that only in the 3 major countries we have a population of 358 million people: Argentina: 35 million; Brazil: 213 million; Mexico: 110 million. This vast population gives access to several therapeutic areas, surpassing all patient enrollment expectations for any clinical study in any therapeutic area.
In Latin America we have Access to huge potential of pediatric disease population (32% of the population under 14 years of age) and access to huge potential of chronic disease population (64% of the population between 15-64 years of age).